Utility of brain natriuretic peptide in the neonatal pathologies

Authors

  • Shriprasad R. Deshpande Children's National Hospital Associate Professor of Pediatrics, The George Washington University 111, Michigan Avenue NW Washington, United States

DOI:

https://doi.org/10.18203/2349-3291.ijcp20202637

Abstract

This is with reference to the recently published article titled ‘N-terminal pro brain natriuretic peptide as a marker of myocardial dysfunction in newborns with perinatal asphyxia’ by Drs. Kariyappa et al.

References

Kariyappa M, Shivarudrappa S. N-terminal pro brain natriuretic peptide as a marker of myocardial dysfunction in newborns with perinatal asphyxia. Int J Contemp Pediatr 2020;7:997-1002.

Jain D, Pandey AK, Das BK, Prasad R. Cardiac Function in Perinatal Asphyxia. Sch J App Med Sci. 2016;4(7):2718-28

Simovic AM, Kosutic JL, Prijic SM, Knezevic JB, Vujic AJ, Stojanovic ND. The role of biochemical markers as early indicators of cardiac damage and prognostic parameters of perinatal asphyxia. Vojnosanitetski pregled. 2014;71(2):149-55.

Reynolds EW, Ellington JG, Vranicar M, Bada HS. Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn Pediatrics. 2004;114(5):1297-304.

Popescu MR, Panaitescu AM, Pavel B, Zagrean L, Peltecu G, Zagrean AM. Getting an Early Start in Understanding Perinatal Asphyxia Impact on the Cardiovascular System. Front Pediatr. 2020;8:68.

Downloads

Published

2020-06-24

Issue

Section

Letter to the Editor